Login / Signup

Rapid modeling of an ultra-rare epilepsy variant in wild-type mice by in utero prime editing.

Colin D RobertsonPatrick DavisRyan R RichardsonPhilip H IfflandDaiana C O VieiraMarilyn SteyertPaige N McKeonAndrea J RomanowskiGarrett CrutcherEldin JašarevićSteffen B E WolffPaige N McKeonPeter B CrinoTracy L BaleIvy E DickAlexandros Poulopoulos
Published in: bioRxiv : the preprint server for biology (2023)
Generating animal models for individual patients within clinically-useful timeframes holds great potential toward enabling personalized medicine approaches for genetic epilepsies. The ability to rapidly incorporate patient-specific genomic variants into model animals recapitulating elements of the patient's clinical manifestations would enable applications ranging from validation and characterization of pathogenic variants to personalized models for tailoring pharmacotherapy to individual patients. Here, we demonstrate generation of an animal model of an individual epilepsy patient with an ultra-rare variant of the NMDA receptor subunit GRIN2A, without the need for germline transmission and breeding. Using in utero prime editing in the brain of wild-type mice, our approach yielded high in vivo editing precision and induced frequent, spontaneous seizures which mirrored specific elements of the patient's clinical presentation. Leveraging the speed and versatility of this approach, we introduce PegAssist, a generalizable workflow to generate bedside-to-bench animal models of individual patients within weeks. The capability to produce individualized animal models rapidly and cost-effectively will reduce barriers to access for precision medicine, and will accelerate drug development by offering versatile in vivo platforms to identify compounds with efficacy against rare neurological conditions.
Keyphrases